196
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Design, formulation and optimization of topical ethosomes using full factorial design: in-vitro and ex-vivo characterization

ORCID Icon
Pages 74-82 | Received 13 Apr 2021, Accepted 05 Jul 2021, Published online: 26 Oct 2021

References

  • Abd-Elbary, A., El-Laithy, H.M., and Tadros, M.I., 2008. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. International journal of pharmaceutics, 357 (1–2), 189–198.
  • Abdel Messih, H.A., et al., 2017. Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation. Drug development and industrial pharmacy, 43 (6), 958–971.
  • Abdelbary, G., et al., 2011. Toluidine blue loaded transferosomes for topical photodynamic therapy: formulation and characterization. International journal of research in pharmaceutical sciences, 2, 537–544.
  • Abdelkader, H., Alani, A.W., and Alany, R.G., 2014a. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug delivery, 21 (2), 87–100.
  • Abdelkader, H., Farghaly, U., and Moharram, H., 2014b. Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. Journal of pharmaceutical investigation, 44 (5), 329–337.
  • Abdulbaqi, I.M., et al., 2016. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. International Journal of Nanomedicine, 11, 2279–2304.
  • Abousamra, M.M., et al., 2019. A promising nystatin nanocapsular hydrogel as an antifungal polymeric carrier for the treatment of topical candidiasis. Journal of drug delivery science and technology, 49, 365–374.
  • Aditya, N.P., et al., 2013. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. Journal of agricultural and food chemistry, 61 (8), 1878–1883.
  • Ahad, A., et al., 2012. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine: nanotechnology, biology, and medicine, 8 (2), 237–249.
  • Ahmed, T.A., 2020. Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity. BMC pharmacology & toxicology, 21 (1), 1–12.
  • Basha, M., et al., 2018. A potential antibacterial wound dressing of cefadroxil chitosan nanoparticles in situ gel: fabrication, in vitro optimization and in vivo evaluation. International journal of pharmaceutics, 544 (1), 129–140.
  • Beberok, A., et al., 2013. Cytotoxic effect of lomefloxacin in culture of human epidermal melanocytes. Pharmacological reports, 65 (3), 689–699.
  • Benson, H.A., 2009. Elastic liposomes for topical and transdermal drug delivery. Methods in molecular biology, 605, 77–86.
  • Bragagni, M., et al., 2012. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug delivery, 19 (7), 354–361.
  • Celia, C., et al., 2012. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders. Biomedical microdevices, 14 (1), 119–130.
  • Chandra, A., et al., 2019. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharmaceutical nanotechnology, 7 (5), 362–374.
  • Chen, Z.X., et al., 2017. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. European journal of pharmaceutical sciences, 99, 240–245.
  • Chhibber, T., Gondil, V.S., and Sinha, V.R., 2020. Development of chitosan-based hydrogel containing antibiofilm agents for the treatment of staphylococcus aureus-infected burn wound in mice. AAPS PharmSciTech, 21 (2), 1–12.
  • Choi, J.H., et al., 2015. Ethosomes and transfersomes for topical delivery of ginsenoside Rhl from red ginseng: characterization and in vitro evaluation. Journal of nanoscience and nanotechnology, 15 (8), 5660–5662.
  • Dubey, V., et al., 2010. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomedicine, 6 (4), 590–596.
  • El-Laithy, H.M., Shoukry, O., and Mahran, L.G., 2011. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. European journal of pharmaceutics and biopharmaceutics, 77 (1), 43–55.
  • Elsayed, M.M., et al., 2006. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. International journal of pharmaceutics, 322 (1–2), 60–66.
  • Garg, B.J., et al., 2016. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. Journal of drug targeting, 24 (3), 233–246.
  • Garg, V., et al., 2017. Ethosomes and transfersomes: principles, perspectives and practices. Current drug delivery, 14 (5), 613–633.
  • Ghanbarzadeh, S. and Arami, S., 2013. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. Biomed research international, 2013, 1–7.
  • Gomes, G.C. and Salgado, H.R.N., 2005. Validation of UV spectrophotometric method for determination of lomefloxacin in pharmaceutical dosage form. Acta farmaceutica bonaerense, 24, 406–408.
  • Gonzalez-Mira, E., et al., 2010. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids and surfaces. B, Biointerfaces, 81 (2), 412–421.
  • Gorzelanny, C., et al., 2020. Skin barriers in dermal drug delivery: which barriers have to be overcome and how can we measure them? Pharmaceutics, 12 (7), 684.
  • Goyal, R., et al., 2016. Nanoparticles and nanofibers for topical drug delivery. Journal of controlled release, 240, 77–92.
  • Hallan, S.S., et al., 2020. Design and characterization of ethosomes for transdermal delivery of caffeic acid. Pharmaceutics, 12 (8), 1–19.
  • Ibrahim, T.M., et al., 2019. Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol. Journal of liposome research, 29 (3), 215–228.
  • Islam, M.T., et al., 2004. Rheological characterization of topical carbomer gels neutralized to different pH. Pharmaceutical research, 21 (7), 1192–1199.
  • Junyaprasert, V.B., et al., 2012. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. International journal of pharmaceutics, 423 (2), 303–311.
  • Khalil, R.M., et al., 2017a. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl. Journal of liposome research, 27 (2), 118–129.
  • Khalil, R.M., et al., 2017b. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation. Journal of liposome research, 27 (4), 312–323.
  • Khalil, R.M., et al., 2019. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization. Journal of liposome research, 29 (2), 171–182.
  • Khalil, R.M., et al., 2021. Development of tizanidine loaded aspasomes as transdermal delivery system: ex-vivo and in-vivo evaluation. Journal of liposome research, 31 (1), 19–29.
  • Kumar, R. and Philip, A., 2007. Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Tropical journal of pharmaceutical research, 6, 633–644.
  • Limsuwan, T. and Amnuaikit, T., 2012. Development of ethosomes containing mycophenolic acid. Procedia chemistry, 4, 328–335.
  • Lu, J., et al., 2020. Recent developments in the principles, modification and application prospects of functionalized ethosomes for topical delivery. Current drug delivery, 18 (5), 570–582.
  • Natsheh, H. and Touitou, E., 2020. Phospholipid vesicles for dermal/transdermal and nasal administration of active molecules: the effect of surfactants and alcohols on the fluidity of their lipid bilayers and penetration enhancement properties. Molecules, 25 (13), 1–42.
  • Peram, M.R., et al., 2019. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation. Journal of liposome research, 29 (3), 291–311.
  • Rahman, S.A., et al., 2016. Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients. Drug delivery, 23 (4), 1184–1193.
  • Rushmi, Z.T., et al., 2017. The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia. Saudi pharmaceutical journal, 25 (3), 404–412.
  • Salama, A., Hegazy, R., and Hassan, A.J.P.O., 2016. Intranasal chromium induces acute brain and lung injuries in rats: assessment of different potential hazardous effects of environmental and occupational exposure to chromium and introduction of a novel pharmacological and toxicological animal model. PLoS One, 11 (12), 1–20.
  • Sato, H., et al., 1996. Pharmacokinetics of norfloxacin and lomefloxacin in aqueous humour analysed by microdialysis. Japanese journal of ophthalmology, 100, 513–519.
  • Shah, P., et al., 2020. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. Pharmaceutics, 12 (3), 1–29.
  • Shen, L.N., et al., 2014. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. International journal of pharmaceutics, 460 (1–2), 280–288.
  • Touitou, E., et al., 1997. Ethosomes: novel lipid vesicular system for enhanced delivery. Pharmaceutical research, 14, 305–306.
  • Touitou, E., et al., 2000. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. Journal of controlled release, 65 (3), 403–418.
  • Verma, P. and Pathak, K., 2010. Therapeutic and cosmeceutical potential of ethosomes: an overview. Journal of advanced pharmaceutical technology & research, 1 (3), 274–282.
  • Verma, S., et al., 2009. Quality by design approach to understand the process of nanosuspension preparation. International journal of pharmaceutics, 377 (1–2), 185–198.
  • Wang, Y., et al., 2020. Antifungal photodynamic activity of hexyl-aminolevulinate ethosomes against Candida albicans biofilm. Frontiers in microbiology, 11, 1–25.
  • Ying, L.Q. and Misran, M., 2017. Rheological and physicochemical characterization of alpha-tocopherol loaded lipid nanoparticles in thermoresponsive gel for topical application. Malaysian journal of fundamental and applied sciences, 13 (3), 248–252.
  • Yu, Z., et al., 2016. Ethosomes loaded with cryptotanshinone for acne treatment through topical gel formulation. PLoS One, 11 (7), 1–11.
  • Zhang, Y.T., et al., 2014. Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis. International journal of nanomedicine, 9, 669–678.
  • Zhou, Y., et al., 2010. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir. Archives of pharmacal research, 33 (4), 567–574.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.